KDM3A antibody (AA 1-300)
Quick Overview for KDM3A antibody (AA 1-300) (ABIN1680576)
Target
See all KDM3A AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    - 
                                            Binding Specificity
- AA 1-300
- 
                                            Sequence
- MVLTLGESWP VLVGRRFLSL SAADGSDGSH DSWDVERVAE WPWLSGTIRA VSHTDVTKKD LKVCVEFDGE SWRKRRWIEV YSLLRRAFLV EHNLVLAERK SPEISERIVQ WPAITYKPLL DKAGLGSITS VRFLGDQQRV FLSKDLLKPI QDVNSLRLSL TDNQIVSKEF QALIVKHLDE SHLLKGDKNL VGSEVKIYSL DPSTQWFSAT VINGNPASKT LQVNCEEIPA LKIVDPSLIH VEVVHDNLVT CGNSARIGAV KRKSSENNGT LVSKQAKSCS EASPSMCPVQ SVPTTVFKEI
- 
                                            Cross-Reactivity
- Human, Mouse, Rat
- 
                                            Characteristics
- Polyclonal Antibodies
- 
                                            Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 1-300 of human KDM3A (NP_060903.2).
- 
                                            Isotype
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Application Notes
- WB,1:500 - 1:2000
- 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
- 
                                            Preservative
- Sodium azide
- 
                                            Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Storage
- -20 °C
- 
                                            Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
 
- 
                                            
- 
    - 
                                            : "Global histone modification profiling reveals the epigenomic dynamics during malignant transformation in a four-stage breast cancer model."    in: Clinical epigenetics, Vol. 8, pp. 34, (2016)         (PubMed).        
 
 
- 
                                            : "Global histone modification profiling reveals the epigenomic dynamics during malignant transformation in a four-stage breast cancer model."    in: Clinical epigenetics, Vol. 8, pp. 34, (2016)         (PubMed).        
- 
    - KDM3A (Lysine (K)-Specific Demethylase 3A (KDM3A))
- 
                                            Alternative Name
- KDM3A
- 
                                            Background
- This gene encodes a zinc finger protein that contains a jumonji domain and may play a role in hormone-dependent transcriptional activation. Alternative splicing results in multiple transcript variants.,KDM3A,JHDM2A,JHMD2A,JMJD1,JMJD1A,TSGA,Epigenetics & Nuclear Signaling,Chromatin Modifying Enzymes,Demethylation,KDM3A
- 
                                            Molecular Weight
- 147 kDa
- 
                                            Gene ID
- 55818
- 
                                            UniProt
- Q9Y4C1
- 
                                            Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway, Nuclear Hormone Receptor Binding, Warburg Effect
 Target
- 
                    
 
                                     
                                     
                                    